Rescue Quadratus Lumborum Blocks for Post-cesarean Pain
NCT ID: NCT04397458
Last Updated: 2023-11-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
PHASE4
INTERVENTIONAL
2022-01-01
2022-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quadratus Lumborum Block for Post-Cesarean Analgesia
NCT02339766
Effect of Bilateral Quadratus Lumborum Block for Pain Relief in Patients With Cesarean Section
NCT03199170
Quadratus Lumborum in Cesarean Section Trial
NCT03673280
Postoperative Analgesia After Cesarean Section; Comparison Among Ultrasound Guided Erector Spinae, Quadratus Lumborum or Transversus Abdominis Plane Blocks
NCT06451354
Dexamethasone for Post-operative Pain After Cesarean Delivery Under Neuraxial Anesthesia.
NCT07257406
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sham Control
20 milliliters (mL) 0.9% saline on each side
Saline
0.9% saline on each side
Quadratus Lumborum Block
20 mL solution with 0.25% bupivacaine (50 milligrams (mg)) and 3mg preservative-free dexamethasone on each side
Bupivacaine
0.25% bupivacaine (50mg) on each side
Dexamethasone
3mg preservative-free dexamethasone on each side
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Saline
0.9% saline on each side
Bupivacaine
0.25% bupivacaine (50mg) on each side
Dexamethasone
3mg preservative-free dexamethasone on each side
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* pain scores \>5/10
Exclusion Criteria
* obstructive sleep apnea
* drug abuse
* chronic pain
* chronic opioid use
* abdominal surgeries other than cesarean delivery
* contraindications to neuraxial or regional anesthesia
* received general anesthesia or did not receive neuraxial morphine for cesarean delivery
18 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The University of Texas Health Science Center, Houston
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maya Suresh
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Linden Lee, MD
Role: PRINCIPAL_INVESTIGATOR
The University of Texas Health Science Center, Houston
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The University of Texas Health Science Center at Houston
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HSC-MS-20-0124
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.